BNF presentation directory

Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.

Chapter

Reset

Presentation	Product	Chemical substance	Chapter	Items dispensed
SodiBic 420mg/5ml (1mmol/ml) oral solution 0101012B0BCAAAB	SodiBic	Sodium bicarbonate	Gastro-Intestinal System	296
Glycopyrronium bromide 5mg/5ml oral solution 0102000L0AABFBF	Glycopyrronium bromide (Oral)	Glycopyrronium bromide	Gastro-Intestinal System	295
Sod algin 225mg/Mag algin 87.5mg/dose oral pdr sach SF 0101021B0AAAJAJ	Alginic acid compound preparation	Alginic acid compound preparations	Gastro-Intestinal System	293
Arachis oil 130ml enema 0106030A0AAAAAA	Arach oil (Enema)	Arachis oil	Gastro-Intestinal System	282
Cimetidine 800mg tablets 0103010D0AAACAC	Cimetidine	Cimetidine	Gastro-Intestinal System	281
Anusol Soothing Relief ointment 0107020J0BCAFAC	Anusol HC	Hydrocortisone	Gastro-Intestinal System	280
Belladonna medicated plaster 9.5cm x 12.5cm 0102000H0AAAMAM	Belladonna (Alkaloids)	Belladonna alkaloids	Gastro-Intestinal System	280
Sod dihydrogen phos anhydrous 680mg/Sod bicarb 500mg suppos 0106040N0AAAFAF	Phosphate (Rectal)	Phosphates (Rectal)	Gastro-Intestinal System	279
Magnesium oxide 500mg capsules 0101010I0AAAYAY	Magnesium oxide	Magnesium oxide	Gastro-Intestinal System	273
Zinc oxide 6.6% / Lidocaine 0.7% ointment 0107010N0AAAHAH	Lidocaine hydrochloride (Rectal)	Lidocaine hydrochloride	Gastro-Intestinal System	273
Lecicarbon C suppositories 0106040N0BEACAG	Lecicarbon	Phosphates (Rectal)	Gastro-Intestinal System	269
Preparation H 50% clear gel 0107010I0BBAAAI	Preparation H (Hamamelis)	Hamamelis	Gastro-Intestinal System	269
Hyoscine butylbromide 10mg/5ml oral solution 0102000N0AAAPAP	Hyoscine butylbromide	Hyoscine butylbromide	Gastro-Intestinal System	266
Apercap 0.2ml gastro-resistant capsules 0102000T0BIAAAA	Apercap	Peppermint oil	Gastro-Intestinal System	252
Bisacodyl 10mg/30ml enema 0106020C0AAAXAX	Bisacodyl	Bisacodyl	Gastro-Intestinal System	248
Tagamet 200mg/5ml syrup 0103010D0BBADAD	Tagamet	Cimetidine	Gastro-Intestinal System	242
Loperamide 2mg oral lyophilisates sugar free 0104020L0AAATAT	Loperamide hydrochloride	Loperamide hydrochloride	Gastro-Intestinal System	233
Ursofalk 250mg/5ml oral suspension 0109010U0BCABBE	Ursofalk	Ursodeoxycholic acid	Gastro-Intestinal System	225
Bismuth subsalicylate 262.5mg chewable tablets sugar free 010102100AAAIAI	Generic compound preparation BNF 0101021	Compound alginates and proprietary indigestion preparations	Gastro-Intestinal System	223
Gaviscon Strawberry chewable tablets 0101021B0BEAWAR	Gaviscon	Alginic acid compound preparations	Gastro-Intestinal System	216
Glyceryl trinitrate 0.2% ointment 0107040A0AAAWAW	Glyceryl trinitrate (Haemorrhoids)	Glyceryl trinitrate	Gastro-Intestinal System	209
Oromag 160 capsules 0101010I0BEAAAC	Oromag 160	Magnesium oxide	Gastro-Intestinal System	204
Colofac IBS 135mg tablets 0102000P0BCACAB	Colofac	Mebeverine hydrochloride	Gastro-Intestinal System	202
Audmonal 60mg capsules 0102000A0BDAAAA	Audmonal	Alverine citrate	Gastro-Intestinal System	201
Co-danthramer 25mg/200mg/5ml oral suspension sugar free 0106020B0AAAAAA	Co-danthramer	Co-danthramer (Dantron/poloxamer 188)	Gastro-Intestinal System	201

Why monitor BNF codes?

Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.

Track cost pressure

Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.

Understand demand drivers

Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.